AllianceBernstein
SLXP

AllianceBernstein’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

AllianceBernstein’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,300
Closed -$1.27M – 3514
2014
Q2 		$1.27M Hold
10,300
– – ﹤0.01% 2103
2014
Q1 		$1.07M Buy
+10,300
New +$1.05M ﹤0.01% 2133

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

AllianceBernstein's SLXP Position: Q2 2015 in Review

AllianceBernstein sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 50,641 shares — an estimated $8.75M sold.

AllianceBernstein first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $10.4M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • AllianceBernstein reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • AllianceBernstein sold 50,641 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $8.75M.
  • AllianceBernstein first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • AllianceBernstein's SALIX PHARMACEUTICALS LTD DEL position peaked at $10.4M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on AllianceBernstein's 13F filing for Q2 2015, filed 14 Aug 2015.